Abstract: A method for whitening teeth which utilizes laser light to activate bleaching agents applied to the teeth. The mouth is first prepared so that the soft tissues of the gums are protected and only the teeth are exposed. The teeth are cleaned to remove any materials which will reduce or nullify the effects of the bleaching agents. A mixture of peroxide and a first catalyst are prepared and applied to the teeth. The teeth are exposed to laser light from an argon laser which light activates the peroxide and catalyst to accelerate the bleaching process without heat. Next, a mixture of peroxide and a second catalyst are prepared and applied to the teeth. The teeth are briefly exposed to laser light from a carbon dioxide laser which heat activates the peroxide and catalyst to accelerate the bleaching process.

Abstract: A cosmetic composition comprising a hydroxy material selected from;a) layered double hydroxides of formula[M.sub.(1-a) N.sub.a (OH).sub.2 ].sup.y+ X.sup.x-.sub.y/x.zH.sub.2 O(I)b) a hydroxy salt of formula[M'(OH).sub.(2-a') ].sup.a'+ (X.sup.x-).sub.(a'-/x).zH.sub.

Abstract: A composition for the treatment of premenstrual syndrome comprising an effective amount of calcium, magnesium, an analgesic and a diuretic sufficient to reduce the symptoms of premenstrual syndrome.

Abstract: Biowaste treatment agents for treating biowastes in a manner which: (a) keeps noxious and toxic substances from being released from the biowaste, and (b) neutralizes such substances released during the course of stabilizing the biowaste. The treatment agents include a surfactant in an amount of from 1.0 to 99 percent of the treatment agent, a metal component in an amount from 0.5 to 85 percent of the treatment agent, the metal component including a source of zinc, or copper, or a combination of copper with aluminum or iron, and an aldehyde in an amount from 0.1 to 80 percent of the treatment agent.

Abstract: Biowaste treatment agents for treating biowastes in a manner which: (a) keeps noxious and toxic substances from being released from the biowaste, and (b) neutralizes such substances released during the course of stabilizing the biowaste. The treatment agents include a surfactant in an amount of from 1.0 to 99 percent of the treatment agent, a metal component in an amount from 0.5 to 85 percent of the treatment agent, the metal component including a source of zinc, or copper, or a combination of copper with aluminum or iron, and an aldehyde in an amount from 0.1 to 80 percent of the treatment agent.

Abstract: An anticoagulant for blood contains sodium hydroxide, citric acid and sodium hexametaphosphate. A method of preventing the clotting of blood using the anticoagulant also is disclosed.

Abstract: A method of installing in a building a suspension containing paramagnetic susceptible elements consisting essentially of:(A) providing in a non-metallic container 5-12 pounds of a composition consisting essentially of (i) 30-99 wt % of a carbonate or a mixture of two or more carbonates selected from the group consisting of magnesium carbonate, calcium carbonate, strontium carbonate, barium carbonate and mixtures thereof, wherein the carbonate or mixture of carbonates are in powder form, (ii) 1-70 wt % of activated carbon in powder form, (iii) 0.

Abstract: This invention provides a co-micronized bicarbonate salt composition which is a blend of ingredients having a particle size between about 0.01-1.0 micron. The composition is produced by mill co-micronization of a crystalline bicarbonate ingredient and a crystalline inorganic compound ingredient having a Mohs hardness value between about 3-7. A co-micronized blend such as sodium bicarbonate and zinc oxide is free-flowing and essentially free of agglomerated particles.

Abstract: The object of the present invention is to prepare a dried aluminum hydroxide gel featuring excellent acid neutrizing capacity, but which is also stable.A dried aluminum hydroxide gel with a chemical composition represented by the following general formulas:(M.sub.2 O).sub.x Al.sub.2 O.sub.3 (CO.sub.2).sub.y R.sub.z.mH.sub.2 O or[(M.sub.2 O).sub.x1 (CaO).sub.x2 (MgO).sub.x3 ]Al.sub.2 O.sub.3 (CO.sub.2).sub.y R.sub.z.mH.sub.2 O(wherein M is a monovalent alkali metal and R is an organic acid with a valence of two or more. As a result of its organic acid content, the gel is stable and can have a grater aluminum content, thus improving the acid neutrizing capacity of the gel.

Abstract: A composition comprising sucralfate and one or more anti-acid epigastralgic relieving agents in a weight ratio of between 0.5:1.0 to 1.3 sucralfate to anti-acid epigastralgic relieving agent and a method of using the composition for relieving symptoms of gastrointestinal mucosal irritation in mammals. The composition may be either in liquid or solid dose form having a combined composition weight percentage of 10-30% per 5 milliliter volume of liquid or 40-85% per solid unit dose form.

Abstract: A bath additive composition comprises an aluminum salt and a carbonate and makes the pH of bath water 8 or higher but less than 9 when the bath additive composition is dissolved in the bath water. The bath additive composition does not damage bathtubs, bath water heating devices, or the skin of users, provides a refreshing feel to the skin after bathing, and has an excellent ability of suppressing perspiration.

Abstract: An antimicrobial agent contains a calcined product of a calcium oxide type prepared by calcining shells of an oyster and/or a calcined product of a calcium hydroxide type as a hydrate of the calcined product of the calcium oxide type.

Abstract: Compositions comprise carbon particles combined with white odor-controlling agents by means of binders. The preferred particle form of the compositions is substantially lighter in color than the original carbon, and the resulting particles are preferred for use in the manufacture of catamenials, diapers, bandages, and the like. Particles comprising carbon coated with zeolites are not only desirably lighter in color, but also control a broad spectrum of malodors associated with body fluids.

Abstract: A calcium ion containing composition comprising a water in oil emulsion having a dispersed aqueous phase and a continuous oil phase, which composition is orally administerable and palatable to cows without causing lesions of the stomach and which composition is effective in preventing milk fever, said composition further comprising a calcium salt which is dissolved in the aqueous phase to form a calcium ion containing aqueous phase solution, the calcium in the composition, calculated as free calcium ion, comprising 10 to 20 percent by weight of the composition, said composition further including from 0.5 to 10 percent oil soluble non-ionic emulsifier. The invention also includes the method of orally administering the composition to cows to treat milk fever.

Abstract: A anti-microorganism agent completely or nearly free of toxicity, insoluble or sparingly soluble in water or an organic solvent so as not to contaminate the environment and highly effective as such, which is composed of at least one of a composite metal hydroxide of the formula (1),(M.sub.1.sup.2+).sub.1-x (M.sub.2.sup.2+).sub.x (OH).sub.2 ( 1)wherein M.sub.1.sup.2+ is at least one of Mg.sup.2+ and Ca.sup.2+, M.sub.2.sup.2+ is at least one of Cu.sup.2+ and Zn.sup.2+, and x is defined by 0.001.ltoreq.x<0.9,anda composite metal oxide of the formula (2),(M.sub.1.sup.2+).sub.1-y (M.sub.2.sup.2+).sub.y O (2)wherein M.sub.1.sup.2+ is at least one of Mg.sup.2+ and Ca.sup.2+, M.sub.2.sup.2+ is at least one of Cu.sup.2+ and Zn.sup.2+, and y is defined by 0.001.ltoreq.y.ltoreq.0.5, and an anti-microorganism resin or rubber composition containing said anti-microorganism agent.

Abstract: This invention relates to a pharmaceutical composition for use in the treatment of pain and inflammation and the treatment of acid indigestion, sour stomach, heartburn and symptoms of upset stomach associated with these conditions in a mammalian organism, said composition comprising:(i) an analgesically and anti-inflammatory effective amount of (S)-ibuprofen, or a salt thereof, substantially free of (R)-ibuprofen;(ii) an amount effective in the treatment of acid indigestion, sour stomach and/or heartburn of at least one of the antacids; and(iii) optionally, an amount effective in treating excess gas and flatulence of an anti-gas agent.

Abstract: An improved method for the production of synthetic hydrotalcites having high purity (99+%) and small particle size (<2 microns) is disclosed. This method used inexpensive and available reactants and is suitable for commercial scale production. A source of magnesium, such as magnesium hydroxide; a source of aluminum from a mixture of alumina trihydrate and an alkali metal aluminate; and a source of carbonate, such as sodium bicarbonate, are reacted under hydrothermal conditions at a temperature of between 160.degree.-200.degree. C. to produce synthetic hydrotalcite.

Abstract: A pharmaceutical composition is provided for the protection of the oesogastroduodenal mucous membrane, which composition has an active antacid component comprising sufficient guar gum to provide antacid and buffering effect at a pH of from 0.8 to 3.5, and at least one antacid agent other than guar gum in an amount effective as an antacid.

Abstract: An agent for desensitization of man and/or animals against an allergen comprising liposomes that comprise the allergen is provided together with a method for inducing desensitization by administration of the agent.

Abstract: A mineral additive to be added to nutrients, feed, and medicaments, and which comprises a source of magnesium is characterized by comprising:(1) magnesium lactate;(2) water soluble, acidic, substantially dibasic magnesium citrate; and if desired(3) magnesium hydroxide; and, if desired additionally(4) a carbohydrate additive.The quantity of magnesium citrate preferably constitutes 5 to 15% by weight, calculated as magnesium.

Abstract: An antibiotic resin composition comprises at least one antibiotic zeolite of which ion-exchangeable ions are partially or completely replaced with ammonium ionsand antibiotic metal ions, at least one discoloration inhibitor and at least one resin. The antibiotic resin composition exhibits excellent antibiotic property and does not discolor with time. Thus, the resin composition can be employed to form a variety of products which require antibacterial and/or antifungus properties.

Abstract: An antibiotic zeolite and an antibiotic resin composition containing thereof are provided. The antibiotic zeolite is prepared by replacing all or a part of ion-exchangeable ions in zeolite with ammonium ions and antibiotic metal ions such as silver, copper, zinc, mercury, tin, lead, bismuth, cadmium, chromium and thallium. The antibiotic resin composition comprises the antibiotic zeolite and a resin such as polyethylene, polypropylene, polyvinyl chloride and polystyrene.

Abstract: Extract of tea leaves or (-)-epigallocatechin gallate as the principal ingredient of the extract forms a complex with active aluminum hydroxide. The animal test using rats has established that these complexes have therapeutic effect for gastric ulcers, e.g. pylorus-ligated ulcer and indomethacin-induced ulcer, when orally administered. Tests were also undertaken for the effect on the secretion of gastric juice and acute toxicity of these complexes using rats and mice as the test animals.

Abstract: A method for preparing a dispersion containing antibiotic powder comprises mixing the antibiotic powder and a dispersing medium at a temperature at which the dispersing medium is in the form of a liquid under a reduced pressure of not more than 470 Torr. According to this method, the antibiotic powder is uniformly dispersed in various dispersing mediums and antibiotic products having high antibiotic action is effectively be provided by using the resulting dispersion.